Cost-effectiveness modelling

被引:4
作者
Barlow, DH
机构
关键词
D O I
10.1093/humrep/16.12.2479
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:2479 / 2480
页数:2
相关论文
共 10 条
[1]  
BARLOW DH, 1994, REPORT ADVISORY GROU
[2]   An introduction to Markov modelling for economic evaluation [J].
Briggs, A ;
Sculpher, M .
PHARMACOECONOMICS, 1998, 13 (04) :397-409
[3]  
Committee for 2011 Guidelines for Prevention and Treatment of Osteoporosis (Director Orimo H), 2011, GUIDELINES PREVENTIO
[4]   HRT - AN ANALYSIS OF BENEFITS, RISKS AND COSTS [J].
DALY, E ;
ROCHE, M ;
BARLOW, D ;
GRAY, A ;
MCPHERSON, K ;
VESSEY, M .
BRITISH MEDICAL BULLETIN, 1992, 48 (02) :368-400
[5]   Hormone replacement therapy in a risk-benefit perspective [J].
Daly, E ;
Vessey, MP ;
Barlow, D ;
Gray, A ;
McPherson, K ;
Roche, M .
MATURITAS, 1996, 23 (02) :247-259
[6]   MEASURING THE IMPACT OF MENOPAUSAL SYMPTOMS ON QUALITY-OF-LIFE [J].
DALY, E ;
GRAY, A ;
BARLOW, D ;
MCPHERSON, K ;
ROCHE, M ;
VESSEY, M .
BRITISH MEDICAL JOURNAL, 1993, 307 (6908) :836-840
[7]   Sponsorship, authorship, and accountability. [J].
Davidoff, F ;
DeAngelis, CD ;
Drazen, JM ;
Hoey, J ;
Hojgaard, L ;
Horton, R ;
Kotzin, S ;
Nicholls, MG ;
Nylenna, M ;
Overbeke, AJPM ;
Sox, HC ;
Van Der Weyden, MB ;
Wilkes, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) :825-827
[8]   Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK [J].
Daya, S ;
Ledger, W ;
Auray, JP ;
Duru, G ;
Silverberg, K ;
Wikland, M ;
Bouzayen, R ;
Howles, CM ;
Beresniak, A .
HUMAN REPRODUCTION, 2001, 16 (12) :2563-2569
[9]   Assessing quality in decision analytic cost-effectiveness models - A suggested framework and example of application [J].
Sculpher, M ;
Fenwick, E ;
Claxton, K .
PHARMACOECONOMICS, 2000, 17 (05) :461-477
[10]   The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments [J].
Sykes, D ;
Out, HJ ;
Palmer, SJ ;
van Loon, J .
HUMAN REPRODUCTION, 2001, 16 (12) :2557-2562